Drs. Miller and Luo will interact with the other investigators in designing experiments, interpreting results, and writing progress reports and manuscripts. The experiments will be performed testing immune-modifying nanoparticles previously developed by Dr. Miller and his collaborators and SA-FasL chimeric proteins.
|Effective start/end date||4/1/15 → 3/31/16|
- University of Wisconsin-Madison (623K976//U01AI102456)
- National Institute of Allergy and Infectious Diseases (623K976//U01AI102456)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.